Funding Data Link References Status API Help
Page 1 of 440 results
Sort by: relevance publication year

Albutrepenonacog alfa (Idelvion®) for the treatment of Italian patients with hemophilia B: a budget impact model

Journal Article published 30 Jan 2018 in Farmeconomia. Health economics and therapeutic pathways volume 19 issue 1

Authors: Lorenzo Pradelli, Sara Villa, Giancarlo Castaman

Estimating the cost-effectiveness of treatment for prevention of thromboembolic events in at-risk adults with non-valvular atrial fibrillation

Journal Article published 27 Feb 2018 in Farmeconomia. Health economics and therapeutic pathways volume 19 issue 1

Authors: Marco Bellone, Lorenzo Pradelli, Mario Bo

Personalized medicine: biomarkers and companion diagnostics

Journal Article published 8 Mar 2018 in Farmeconomia. Health economics and therapeutic pathways volume 19 issue 1

Authors: Renato Bernardini, Giovanni Gancitano, Angela Balice, Rosaria Di Mauro, Giuseppina Cantarella, Matteo Dionisi

Cost-Consequence Analysis of Three Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

Journal Article published 23 May 2018 in Farmeconomia. Health economics and therapeutic pathways volume 19 issue 1

Authors: Giovanni Gancitano, Roberto Ravasio, Matteo Dionisi, Diego Cortinovis

Healthcare Resources Use in Patients with Human Immunodeficiency Virus (HIV). Real-World Evidence From Six Italian Local Health Units

Journal Article published 11 Jul 2018 in Farmeconomia. Health economics and therapeutic pathways volume 19 issue 1

Authors: Valentina Perrone, Diego Sangiorgi, Stefano Buda, Margherita Andretta, Silvio Borrè, Chiara Cattaruzzi, Gina Gasperini, Fabio Lena, Alessia Pisterna, Luca Degli Esposti

Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis

Journal Article published 30 Nov 2018 in Farmeconomia. Health economics and therapeutic pathways volume 19 issue 1

Authors: Diego Centonze, Sergio Iannazzo, Laura Santoni, Cecilia Saleri, Elisa Puma, Luigi Giuliani, Pier Luigi Canonico

A general model for the estimation of societal costs of lost production and informal care in Italy

Journal Article published 20 Feb 2017 in Farmeconomia. Health economics and therapeutic pathways volume 18 issue 1

Authors: Lorenzo Pradelli, Gianni Ghetti

In merito a “Valutazione clinica ed economica dell’introduzione sul mercato italiano della combinazione trametinib + dabrafenib nel trattamento del melanoma in stadio avanzato”

Journal Article published 12 Sep 2017 in Farmeconomia. Health economics and therapeutic pathways volume 18 issue 1

Authors: Matteo Ferrario, Giovanni Giuliani

Recently approved recombinant factor VIII (rFVIII) for the replacement treatment in patients with hemophilia A in Italy

Journal Article published 6 Oct 2017 in Farmeconomia. Health economics and therapeutic pathways volume 18 issue 1

Authors: Daniela Paola Roggeri, Ezio Zanon, Alessandro Roggeri

Equilibrium between resources and expenditure of health sector of Social Security Fund: a case study of Iran

Journal Article published 20 Oct 2017 in Farmeconomia. Health economics and therapeutic pathways volume 18 issue 1

Authors: Azadeh Ahmadi Dashtian, Mohsen Mardali

Varenicline treatment for smoking cessation in high risk patients: a budget impact analysis

Journal Article published 2 Oct 2017 in Farmeconomia. Health economics and therapeutic pathways volume 18 issue 1

Authors: Federico Spandonaro, Letizia Mancusi, Barbara Polistena

Evaluation of the cost saving potential of introducing Benepali® and Flixabi® on the European and Italian markets

Journal Article published 10 Oct 2017 in Farmeconomia. Health economics and therapeutic pathways volume 18 issue 1

Authors: Cristina Negrini, Emi Psachoulia

[Tecfidera® (delayed-release dimethylfumarate) in the treatment of relapsing-remitting multiple sclerosis]

Journal Article published 1 Dec 2017 in Farmeconomia. Health economics and therapeutic pathways volume 18 issue 2S

Authors: Lorenzo Giovanni Mantovani, Gianluca Furneri, Paolo Angelo Cortesi, Maria Pia Amato, Achille Patrizio Caputi, Patrizio Piacentini, Alessandra Solari, Carlo Pozzilli, Giancarlo Comi

Budget impact analysis of dabigatran compared with rivaroxaban in the prevention of the thromboembolic risk in patients with non-valvular atrial fibrillation

Journal Article published 14 Nov 2017 in Farmeconomia. Health economics and therapeutic pathways volume 18 issue 1

Authors: Maria Grazia Celeste, Francesca De Marco, Claudio Fresco, Giuseppe Musumeci, Roberto Ravasio

A cost-effectiveness analysis of E/C/F/TAF vs three boosted regimens in the Italian context

Journal Article published 18 Dec 2017 in Farmeconomia. Health economics and therapeutic pathways volume 18 issue 1

Authors: Lorenzo Pradelli, Giovanni Di Perri, Giuliano Rizzardini, Elisa Martelli, Stefano Giardina, Massimiliano Povero

Utilization patterns of complementary and alternative medicine in Australia, Canada and the United States: popularity of dietary supplements, mind-body and manipulative therapies

Journal Article published 8 May 2017 in Farmeconomia. Health economics and therapeutic pathways volume 18 issue 1

Authors: Marina Luketina Sunjka, Ana Pejcic, Mihajlo Jakovljevic

Budget Impact analysis of the first-line treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) adult patients

Journal Article published 28 Jul 2017 in Farmeconomia. Health economics and therapeutic pathways volume 18 issue 1

Authors: Francesco Mennini, Andrea Marcellusi, Raffaella Viti, Giuseppe Saglio

[Reply to Letter to the Editor in reference to " Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”]

Journal Article published 21 Sep 2017 in Farmeconomia. Health economics and therapeutic pathways volume 18 issue 1

Authors: Lorenzo Pradelli, Paolo Ascierto

Cost-effectiveness analysis of empagliflozin in the treatment of patients with type 2 diabetes and established cardiovascular disease in Italy, based on the results of the EMPA-REG OUTCOME study

Journal Article published 5 Oct 2017 in Farmeconomia. Health economics and therapeutic pathways volume 18 issue 1

Authors: Sergio Iannazzo, Edoardo Mannucci, Odette Reifsnider, Aldo Pietro Maggioni

The cost of a combination Anti-Retroviral Therapy (cART) optimization pathway as maintenance therapy in HIV-1 infected patients

Journal Article published 6 Nov 2017 in Farmeconomia. Health economics and therapeutic pathways volume 18 issue 1

Authors: Roberto Ravasio, Fabio Rigo, Emanuela Lattuada, Ercole Concia, Massimiliano Lanzafame